Niagen Bioscience Statistics
NASDAQ: NAGEHealth Care Medicinal Chemicals and Botanical Products USD
2.72+0.03 (+1.12%)
At close: Oct 7, 4:00 PM ET · Delayed 15 min
After hours: 2.72 0.00%
Niagen Bioscience by the numbers
Niagen Bioscience has a market capitalization of $215.2 million based on 79.13M shares outstanding. Its trailing P/E ratio is 14.3, and its forward P/E is 27.2. The stock trades 11.9% below its 50-day average and 36.4% below its 200-day average.
Average daily trading volume is 595.85K shares, or about $1.6 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
NAGE valuation vs. peer median
| Metric | NAGE | Peer median | Difference |
|---|---|---|---|
| Market cap | $215.22M | $218.47M | -1% |
| Forward P/E | 27.2 | 7.2 | +280% |
| Avg. volume | 595.85K | 207.11K | +188% |
Peer median across 8 companies: MDWD, USNA, ACB, SNDL, FTLF, OBIO, ISPR, BTMD.
Valuation
- Market cap
- $215.22M
- P/E (TTM)
- 14.32
- Forward P/E
- 27.20
- EPS (TTM)
- $0.19
- Shares outstanding
- 79.13M
Price and trading
- Previous close
- 2.69
- Open
- 2.67
- Day range
- 2.65 – 2.76
- 52-week range
- 2.61 – 7.95
- 52-week change
- -62.12%
- Beta
- —
- Volume
- 361.06K
- Average volume
- 595.85K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 3, 2026
Additional statistics
- Market Cap
- 215.22M
- Pe
- 14.32
- Forward Pe
- 27.20
- Eps
- 0.19
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 7.95
- Week52 Low
- 2.61
- Avg Volume
- 595.85K
- Shares Outstanding
- 79.13M
- Ma50
- 3.09
- Ma200
- 4.27
- Earnings Date
- Nov 3, 2026
- Pct From52w High
- -65.79%
- Pct From52w Low
- 4.21%